Source:http://linkedlifedata.com/resource/pubmed/id/11370823
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2001-5-23
|
pubmed:abstractText |
Cancer recurrence is a common problem after esophagectomy for esophageal cancer. Local recurrence is especially problematic because it often negates the palliative benefit of esophagectomy. We conducted a retrospective review to assess the effect of extent of esophageal resection (subtotal or total esophagectomy) on local cancer recurrence. Seventy-four consecutive patients with esophageal cancer underwent esophagectomy at our institution over a four-year period. Their charts were reviewed retrospectively and data was collected on age, gender, histology, stage, tumor location, operation, resection margin status, anastomotic leaks, operative mortality, adjuvant therapy, cancer survival, and local recurrence. Total esophagectomy was done in 19 patients (transhiatal - 3; McKeown - 16) and subtotal esophagectomy was done in the other 55 patients (Lewis - 25; left thoracoabdominal - 30). The two groups were similar with respect to age, gender, histology, stage, anastomotic leaks, operative mortality, adjuvant therapy, and overall survival. Resection margins were positive for residual tumor in 2 out of 19 (11%) total esophagectomies and 9 out of 55 (16%) subtotal esophagectomies (p=0.42). Local recurrence occurred in 3 of 19 (16%) patients treated with total esophagectomy and 23 out of 55 (42%) patients treated with subtotal esophagectomy (p=0.04). We conclude that total esophagectomy is associated with fewer local cancer recurrences than subtotal esophagectomy. We, therefore, recommend total esophagectomy for the surgical treatment of esophageal cancer.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0392-9078
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
17-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11370823-Adenocarcinoma,
pubmed-meshheading:11370823-Carcinoma, Squamous Cell,
pubmed-meshheading:11370823-Combined Modality Therapy,
pubmed-meshheading:11370823-Esophageal Neoplasms,
pubmed-meshheading:11370823-Esophagectomy,
pubmed-meshheading:11370823-Female,
pubmed-meshheading:11370823-Follow-Up Studies,
pubmed-meshheading:11370823-Humans,
pubmed-meshheading:11370823-Male,
pubmed-meshheading:11370823-Middle Aged,
pubmed-meshheading:11370823-Neoplasm Recurrence, Local,
pubmed-meshheading:11370823-Neoplasm Staging,
pubmed-meshheading:11370823-Retrospective Studies,
pubmed-meshheading:11370823-Survival Rate,
pubmed-meshheading:11370823-Time Factors
|
pubmed:year |
2001
|
pubmed:articleTitle |
Local recurrence after total or subtotal esophagectomy for esophageal cancer.
|
pubmed:affiliation |
Dept. of Surgery, McMaster University, Hamilton, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|